Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells.

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Abstract Text:

Christopher R Schlieve,Annie Tam,Bradley L Nilsson,Christopher J Lieven,Ronald T Raines,Leonard A Levin,

Retinal ganglion cells (RGCs) undergo apoptosis after axonal injury, in part regulated by an intracellular superoxide anion burst, for which the target(s) are unknown. Shifting the RGC redox state towards reduction and preventing sulfhydryl oxidation is neuroprotective in vitro and in vivo, implying that one or more sulfhydryls on one or more critical proteins may be involved. We synthesized novel borane-protected analogues of the reductant tris(2-carboxyethyl)phosphine (TCEP) with the intent of increasing cell permeability and improving chemical stability, and tested their ability to increase RGC survival in vitro. Retinal ganglion cells of postnatal day 2-4 Long-Evans rats were retrogradely labeled with 4',6-diamidino-2-phenylindole (DAPI). At postnatal days 11-13 the animals were sacrificed, the retinas enzymatically dissociated and plated on poly-L-lysine-coated 96-well flat-bottomed tissue culture plates for 72 h in Neurobasal-A, B27 supplement lacking antioxidants, and TCEP, bis(3-propionic acid methyl ester)phenylphosphine borane complex (PB1), (3-propionic acid methyl ester)diphenylphosphine borane complex (PB2), or three commercially available phosphines. Viable DAPI-positive RGCs were identified by calcein-AM staining. At 72 h, PB1 was effective at rescuing acutely axotomized RGCs at concentrations from 1 nM to 100 microM. RGC survival with 1 nM PB1 was 174+/-12% of control (p=0.002). Another compound, PB2, rescued RGCs at 10 pM (177+/-24%; p=0.006) and 10 nM (251+/-34%; p=0.004) at 72 h. A PAMPA assay demonstrated that PB1 and PB2 were substantially more permeable than TCEP. These data demonstrate that modified reductants are effective RGC neuroprotectants at picomolar-nanomolar concentrations. We propose that these novel molecules may act by inhibiting the sulfhydryl oxidation effect of an intracellular superoxide burst.

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Publishing Authors By Initials

CR Schlieve,A Tam,BL Nilsson,CJ Lieven,RT Raines,LA Levin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Experimental eye research

VOLUME: 83

Page Numbers: 1252-9

Journal Abbreviation:

ISSN: 0014-4835

DAY: 24

MONTH: 08

YEAR: 2006

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370707

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells.

AFFILIATION: Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 52792, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Exp Eye Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells Related Publications

• A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.
• Altered brain activation during cognitive control in patients with moderate to severe traumatic brain injury.
• Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity.
• Apoptosis is required during early stages of tail regeneration in Xenopus laevis.
• Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence.
• Comment on "Direct measurement of the 'Giant' adiabatic temperature change in Gd5Si2Ge2".
• Decision-making after traumatic brain injury in children: a preliminary study.
• Diffusion tensor imaging in the corpus callosum in children after moderate to severe traumatic brain injury.
• Effect of age on the response to in vitro ischemia and reperfusion of the rabbit bladder.
• Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: response to a standardized grape suspension.
• Effect of short-term outlet obstruction on rat bladder nerve density and contractility.
• Evidence for the regulation of left-right asymmetry in Ciona intestinalis by ion flux.
• H+ pump-dependent changes in membrane voltage are an early mechanism necessary and sufficient to induce Xenopus tail regeneration.
• Hippocampus, amygdala, and basal ganglia morphometrics in children after moderate-to-severe traumatic brain injury.
• Inverse drug screens: a rapid and inexpensive method for implicating molecular targets.
• Is the early left-right axis like a plant, a kidney, or a neuron? The integration of physiological signals in embryonic asymmetry.
• Management of the acute asthmatic attack in childhood.
• Moderators' Summary: Wound Management (Session II).
• New developments in flap techniques.
• One-year follow-up study of suicide attempters treated for drug dependence.
• Periodontal diseases--a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy?
• Predictors of cannabis dependence recovery among epidemiological survey respondents in the United States.
• Second malignant tumors after treatment of nasopharyngeal carcinoma: four case reports and literature review.
• Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells.
• Technology-based training in cognitive behavioral therapy for substance abuse counselors.
• The effects of cyclical oestrogen on bladder and urethral structure and function.
• Treating depression in substance abusers.
• Vascularized fibula graft for the traumatically induced long-bone defect.
• Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats.
• Working memory brain activation following severe traumatic brain injury.